Get Thin MD Tirzepatide Review: Cost, a Price-Lock Promise & Honest Verdict (2026)

Get Thin MD: $299/month for tirzepatide, with a genuine "price-lock promise" — the same price every dose, no hidden fees — a real structural claim worth crediting even where the compounding pharmacy itself remains unnamed. Every fact here comes from the company's own published program.

What Get Thin MD is

Get Thin MD is a nationwide, asynchronous telehealth platform, offering compounded semaglutide and tirzepatide injections plus brand-name Ozempic and Zepbound where appropriate, alongside a broader wellness menu (sermorelin, NAD+, HRT, hair loss). No in-person visit is required.

What Get Thin MD costs

$299/month for tirzepatide. A 3-month compounded semaglutide plan runs $169/month — among the lowest ongoing prices this site has documented. The price-lock promise holds the same monthly figure across every dose, with no hidden fees.

Self-reported results, not a clinical trial

Worth flagging directly: Get Thin MD's headline result claim — 9.6 lbs in 30 days — is on the site, but it comes from self-reported patient data, not a clinical trial. Weigh it accordingly against the peer-reviewed SURMOUNT trial data cited below.

The brand-vs-compounded question

Get Thin MD offers both compounded tirzepatide and brand-name options. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials; brand tirzepatide (Zepbound) is the exact molecule and dose that was. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Get Thin MD's real strengths: a genuine price-lock promise across every dose, both compounded and brand-name options, nationwide async availability with no in-person visit required, and among the lowest ongoing compounded prices in the category. The trade-offs: this review found no named pharmacy partner — no way to independently verify the compounding source or batch testing — no published state list despite the nationwide claim, and its headline result figure comes from self-reported data, not a trial. The broader wellness funnel may also steer you toward non-weight-loss protocols. As with any GLP-1 program, confirm your state's coverage and treat the self-reported result figure as anecdotal rather than clinical; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Get Thin MD's genuine price-lock promise and low ongoing semaglutide pricing are real positives, confirmed directly, but this review found no named pharmacy partner — ask directly before committing, and treat the self-reported 9.6-lb result as anecdotal rather than clinical. If a named pharmacy matters more to you, compare it against BiltRx or EverSlim. See our best tirzepatide providers ranking for the full field.